Zydus Pharmaceuticals Limited - Company Profile

Q: Who are the current directors of Zydus Pharmaceuticals Limited?

The current directors of Zydus Pharmaceuticals Limited are Prashant Sharma, Jignesh Batukbhai Thosani, Vishal Bharatkumar Shah, Chimanlal Purushottamdas Patel, Mukund Anand Thakkar, Sujatha Rajesh, Dhaval Narendra Soni.

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 2019.

2019 Ahmedabad, Gujarat, India Active

Last Updated: February 06, 2026

Access Report

About Zydus Pharmaceuticals Limited

Zydus Pharmaceuticals Limited, a active public limited company, was established on 26 December 2019 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290GJ2019PLC111689. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1,000.00 Cr and a paid-up capital of ₹1,000.00 Cr.

Formerly known as Alidac Healthcare Limited. It upholds a compliant status. Its leadership includes Prashant Sharma (Director), Vishal Bharatkumar Shah (Whole-Time Director), Chimanlal Purushottamdas Patel (Director). Past directors included Sujatha Rajesh, Dhavlal Narendra Soni. Its latest AGM occurred on 02 August 2025, with the balance sheet filed on 31 March 2025. It is based at Zydus Corporate Park, Scheme No. 63, Survey No. 536, S.G. Highway, Ahmedabad, Gujarat, 382481.

Company Details

CIN/LLPIN
U24290GJ2019PLC111689
Registration Number
111689
Incorporation Date
26 December 2019
Authorized Capital
₹1,000.00 Cr
Paid-Up Capital
₹1,000.00 Cr
ROC Code
Roc Ahmedabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1,000.00 Cr as on 06-02-2026
Paid Up Capital ₹ 1,000.00 Cr as on 06-02-2026
Company Age 6 Year, 1 Month
Last Filing with ROC 31 Mar 2025
Revenue Growth **** 1206.77% (FY 2023)
Profit Growth **** -987.22% (FY 2023)
Ebitda **** -168.18% (FY 2023)
Net Worth -108.25% (FY 2023)
Total Assets **** 61.47% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Zydus Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Zydus Pharmaceuticals Limited?

Current Directors

Name	Designation	Appointment Date	Status
Prashant Sharma	Director	26 Dec 2019	Current
Vishal Bharatkumar Shah	Whole-Time Director	25 May 2020	Current
Chimanlal Purushottamdas Patel	Director	26 Dec 2019	Current
Mukund Anand Thakkar	Director	26 Dec 2019	Current
Sujatha Rajesh	Director	10 May 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	04 Aug 2024	Past
Pramod Abcsdd	Company Secretary	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Zydus Pharmaceuticals.

Zydus Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1206.77% increase. The company also saw a substantial fall in profitability, with a 987.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 108.25%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

1206.77%

*******

Revenue from Operations

*******

1206.02%

*******

Total Assets

*******

61.47%

*******

Profit or Loss

*******

-987.22%

*******

Net Worth

*******

-108.25%

*******

EBITDA

*******

-168.18%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Zydus Pharmaceuticals?

In 2023, Zydus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Zydus Pharmaceuticals?

Unlock and access historical data on people associated with Zydus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Zydus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zydus Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Zydus Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

Progress on Zydus Pharmaceuticals Limited last Annual general meeting of members was held on 02 Aug 2025 as per latest MCA records. was documented.
02 Aug 2025
Balance Sheet

The activity Zydus Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
31 Mar 2025
Director Appointment

Sujatha Rajesh was appointed as a Director was appointed as a Director on 10 May 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
10 May 2024
Director Appointment

Progress on Jignesh Batukbhai Thosani was appointed as a CFO was appointed as a CFO on 25 May 2020 & has been associated with this company since 5 years 8 months . was documented.
25 May 2020
Director Appointment

Vishal Bharatkumar Shah was appointed as a Whole-time director was appointed as a Whole-time director on 25 May 2020 & has been associated with this company since 5 years 8 months . was recorded as a recent event.
25 May 2020
Director Appointment

The activity Dhaval Narendra Soni was appointed as a Company Secretary was appointed as a Company Secretary on 25 May 2020 & has been associated with this company since 5 years 8 months . was completed.
25 May 2020

Explore recent activity and updates - View Recent Activity